Milestone reflects Eli Lilly and Company's commitment to bring new treatment options to millions of men who experience urological conditions INDIANAPOLIS, Sept. 21, 2012 /PRNewswire/ -- Eli Lilly and ...

Study Data Shows Cialis 5 mg Initiated with Finasteride Provides Significantly Greater Improvements in Urinary Symptoms of Benign Prostatic Hyperplasia than Placebo with Finasteride INDIANAPOLIS, Oct.

Studies showed drug significantly improved scores of sexual function and symptoms of BPH. FDA approved Eli Lilly’s Cialis® as a once-daily treatment for men with both erectile dysfunction (ED) and ...

(Reuters) - U.S. drug regulators approved Eli Lilly's Cialis drug to treat enlargement of the prostate on Thursday, expanding use of the blockbuster impotence medicine. The Food and Drug ...

The European Commission approved Eli Lilly’s Cialis 5 mg (tadalafil) for treating the signs and symptoms of benign prostatic hyperplasia (BPH). EU clearance adds a new indication for the drug in ...

Dear Doctor: What is your opinion of using Cialis to treat benign prostatic hyperplasia? And what should the dosage be? Dear Reader: Cialis (tadalafil) may be most familiar as an effective drug for ...

INDIANAPOLIS — The Food and Drug Administration has approved a new use for a drug made by Eli Lilly for erectile dysfunction, Lilly said Friday. The FDA approved Cialis (tadalafil) as a once-daily ...

Zuellig Pharma is a leading healthcare solutions company in Asia, and our purpose is to make healthcare more accessible to ...

MIAMI, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company, today announced that the clinical trial of the Company’s proprietary Tadalafil and ...

Cialis becomes only medication approved in the EU for both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia INDIANAPOLIS, Oct. 30, 2012 /PRNewswire/ -- Eli Lilly and Company ...